Valuation: Terumo Corporation

Market Cap 3,309B 20.98B 18.64B 17.4B 15.86B 29.91B 2,017B 30.19B 211B 81.6B 1,031B 78.78B 77.07B P/E 2027 *
16.9x
P/E 2028 * 17.2x
Enterprise Value 3,355B 21.27B 18.9B 17.64B 16.08B 30.33B 2,045B 30.61B 213B 82.73B 1,045B 79.87B 78.14B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.45x
Free-Float
97.34%
Yield 2027 *
1.65%
Yield 2028 * 1.77%
1 day-4.59%
1 week-2.31%
Current month-2.33%
1 month-9.13%
3 months+1.31%
6 months+3.63%
Current year-1.17%
1 week 2,243.5
Extreme 2243.5
2,361.5
1 month 2,194.5
Extreme 2194.5
2,463.5
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-4.59%-2.31%-5.95%+14.96% 20.98B
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average -0.69%-1.00%-9.98%+12.70% 71.12B
Weighted average by Cap. -0.11%-1.33%-16.06%+10.27%

Financials

2027 *2028 *
Net sales 1,262B 8B 7.11B 6.63B 6.05B 11.4B 769B 11.51B 80.28B 31.11B 393B 30.03B 29.38B 1,342B 8.51B 7.56B 7.06B 6.43B 12.13B 818B 12.24B 85.39B 33.09B 418B 31.95B 31.25B
Net income 194B 1.23B 1.09B 1.02B 931M 1.76B 118B 1.77B 12.36B 4.79B 60.53B 4.62B 4.52B 193B 1.22B 1.09B 1.01B 924M 1.74B 117B 1.76B 12.27B 4.75B 60.07B 4.59B 4.49B
Net Debt 45.99B 292M 259M 242M 220M 416M 28.03B 420M 2.93B 1.13B 14.33B 1.09B 1.07B -26.39B -167M -149M -139M -126M -239M -16.09B -241M -1.68B -651M -8.22B -628M -615M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
02/10/26 JPY 2,243.50 -4.59% 6,653,200
01/10/26 JPY 2,351.50 +2.37% 6,566,900
30/09/26 JPY 2,297.00 +0.86% 6,905,000
29/09/26 JPY 2,277.50 -0.52% 4,840,400
28/09/26 JPY 2,289.50 -0.30% 5,905,500
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,243.50JPY
Average target price
3,121.54JPY
Spread / Average Target
+39.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock